Department of Surgery/Division of Orthopedic Surgery, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, United States.
Department of Surgery/Division of Orthopedic Surgery, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, United States.
Curr Opin Cell Biol. 2019 Dec;61:39-47. doi: 10.1016/j.ceb.2019.07.008. Epub 2019 Aug 2.
SOX9 is a pivotal transcription factor in chondrocytes, a lineage essential in skeletogenesis. Its mandatory role in transactivating many cartilage-specific genes is well established, whereas its pioneer role in lineage specification, which along with transactivation defines master transcription factors, remains to be better defined. Abundant, but yet incomplete evidence exists that intricate molecular networks control SOX9 activity during the multi-step chondrogenesis pathway. They include a highly modular genetic regulation, post-transcriptional and post-translational modifications, and varying sets of functional partners. Fully uncovering SOX9 actions and regulation is fundamental to explain mechanisms underlying many diseases that directly or indirectly affect SOX9 activities and to design effective disease treatments. We here review current knowledge, highlight recent discoveries, and propose new research directions to answer remaining questions.
SOX9 是软骨细胞中的关键转录因子,在骨骼发生中是必不可少的谱系。它在转录激活许多软骨特异性基因中的必需作用已得到充分证实,而其在谱系特化中的先驱作用,以及转录激活定义主转录因子,仍有待更好地定义。大量但尚未完全的证据表明,复杂的分子网络在多步软骨发生途径中控制 SOX9 的活性。它们包括高度模块化的遗传调控、转录后和翻译后修饰,以及不同的功能伙伴集。充分揭示 SOX9 的作用和调控对于解释许多直接或间接影响 SOX9 活性的疾病的机制以及设计有效的疾病治疗方法至关重要。在这里,我们回顾了当前的知识,强调了最近的发现,并提出了新的研究方向来回答剩余的问题。